EUVIMEDEUVIMED entdecken
Validierungsstudie

Use of dried plasma spots to monitor rifampicin concentrations in resource-constrained settings

S Santhosh, B W Aruldhas, D J Christopher, R Prabha, B Thangagunam, B S Mathew

The International Journal of Tuberculosis and Lung Disease · 27.03.2026 · 30 (4) · 174-179

DOI: 10.5588/ijtld.25.0332 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 27.03.2026. Verfasst von S Santhosh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India. Hauptthemen laut MEDLINE: Rifampin, Drug Monitoring, Antibiotics, Antitubercular, Dried Blood Spot Testing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND

Tuberculosis remains to be the leading cause of mortality amongst infectious diseases with rifampicin being the cornerstone of treatment. However, subtherapeutic concentrations of rifampicin can contribute to treatment failure and drug resistance. Therapeutic drug monitoring (TDM) is essential but challenging in resource-limited settings. This study evaluated the analytical technique of rifampicin quantification using high-performance liquid chromatography (HPLC) from dried plasma spots (DPS), followed by a clinical validation comparing DPS and plasma samples to quantify rifampicin in patients with TB.





METHODS

An HPLC (with ultraviolet detector) assay was developed and validated to estimate rifampicin from DPS (prepared from Whatman ® Grade 1 filter paper). Clinical validation involved 61 patients with TB, where the association and bias of rifampicin concentration between DPS and its respective plasma samples were estimated using weighted Deming regression and Bland–Altman analysis.





RESULTS

The DPS assay demonstrated an acceptable overall bias (range: −10.2% to 8.5%) and precision (intra-day and inter-day coefficient of variation < 7%) at different concentrations. Stability of rifampicin in DPS samples was established for up to 12 days at room temperature. Clinical validation confirmed the need for a correction equation to predict plasma rifampicin concentration from the DPS concentration. The predictive model had a mean bias of 0.27 µg/mL, sensitivity of 93.8%, and specificity of 91.1% for identifying therapeutic concentrations (8–24 µg/mL).





CONCLUSION

DPS using Whatman ® Grade 1 filter paper is a reliable and cost-effective alternative sampling strategy for TDM of rifampicin, particularly in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinDrug MonitoringAntibiotics, AntitubercularDried Blood Spot TestingTuberculosisHumansChromatography, High Pressure LiquidReproducibility of ResultsResource-Limited SettingsAntitubercular Agents

Substanzen

RifampinAntibiotics, AntitubercularAntitubercular Agents

Autor:innen und Institutionen

  • Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India.
  • Department of Pulmonary Medicine, Christian Medical College, Vellore, India.

Zitieren

APA

Santhosh, S., Aruldhas, B. W., Christopher, D. J., Prabha, R., Thangagunam, B., & Mathew, B. S. (2026). Use of dried plasma spots to monitor rifampicin concentrations in resource-constrained settings. The International Journal of Tuberculosis and Lung Disease, 30(4), 174-179. https://doi.org/10.5588/ijtld.25.0332

Vancouver

Santhosh S, Aruldhas BW, Christopher DJ, Prabha R, Thangagunam B, Mathew BS. Use of dried plasma spots to monitor rifampicin concentrations in resource-constrained settings. The International Journal of Tuberculosis and Lung Disease. 2026;30(4):174-179. doi:10.5588/ijtld.25.0332

BibTeX
@article{Santhosh2026,
  author = {Santhosh, S and Aruldhas, B W and Christopher, D J and Prabha, R and Thangagunam, B and Mathew, B S},
  title = {Use of dried plasma spots to monitor rifampicin concentrations in resource-constrained settings},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2026},
  volume = {30},
  number = {4},
  pages = {174--179},
  doi = {10.5588/ijtld.25.0332}
}
Kostenlos starten →